CCPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Oligomerixoligomerix.com EDJPBC |
Oligomerix is a privately held clinical-stage biotechnology company developing oral small molecule therapeutics that inhibit tau s | Bronx, New York | 11-50 | — |
AC Immune SAacimmune.com APWB  DL |
AC Immune SA is a clinical-stage biopharmaceutical company developing precision medicine for neurodegenerative diseases, including | Lausanne, Vaud | 51-200 | — |
Annovisbioannovisbio.com CF  HM AM |
Annovis Bio (NYSE: ANVS) is a Phase 3 clinical-stage biotechnology company developing oral therapies for neurodegenerative disease | Malvern, Pennsylvania | 11-50 | — |
Acoraiacorai.com  CS MD JB |
Acorai is a medical device company developing the Acorai Heart Monitor, a non-invasive cardiac and pulmonary pressure sensing syst | — | — | — |
Tucanatucana.com  KG |
— | — | — | |
Acnpharmaacnpharma.com |
— | — | — | |
Anavex Life Sciencesanavex.com  DKDG JD |
Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company developing novel therapeutics for neurode | New York City, New York | 11-50 | — |
| Run live for more | ||||
Oligomerix is a privately held clinical-stage biotechnology company developing oral small molecule therapeutics that inhibit tau self-association, targeting protein aggregation in Alzheimer's disease and rare tauopathies such as progressive supranuclear palsy (PSP) and frontotemporal dementia.
Companies like Oligomerix include AC Immune SA, Annovisbio, Acorai, Tucana, Acnpharma. See the full list of 24 competitors and alternatives above.
Oligomerix has approximately 11-50 employees and is in the Biotechnology Research industry.
Oligomerix is headquartered in Bronx, New York.
Oligomerix operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Oligomerix are listed above, including leaders across executive, finance, sales and operations.